Cn /En

News Center

——

Company news

Industry news

InnoModels Biotechnology: Unique Features of the CDX Modeling Platform

Author:

InnoModels

Release time:

2024-04-12

In the field of biomedicine, tumor research has always been a key area pursued by researchers. In order to more accurately and deeply study the occurrence, development and treatment process of tumors, many research institutions and enterprises are exploring and improving various experimental models. The CDX model platform launched by InnoModels Biotechnology, with its unique features, is leading the new direction of tumor research.
1. Highly reproducible real tumor environment
CDX model, i.e. patient-derived xenograft model, refers to the transplantation of patient's tumor tissues into immunodeficient mice so that they can grow and develop in the new host environment. By virtue of its exquisite technology and strict operation procedures, the CDX model platform of InnoModels Biotechnology can highly reproduce the real tumor environment and ensure that the transplanted tumor tissues are highly consistent with the original tumors in terms of their biological characteristics and growth patterns.
2. Research on personalized treatment strategies
The CDX model platform allows researchers to conduct research on tumor tissues of specific patients so as to develop personalized treatment strategies for patients. By monitoring and analyzing the growth of a patient's tumor tissue in vivo, researchers can evaluate the efficacy of different drugs or treatments, and thus screen out the most suitable treatment plan for the patient.
3、Efficient drug screening and R&D
Drug screening and R&D is an important part of tumor research. By simulating the real tumor environment, InnoModels' CDX model platform can more accurately reflect the efficacy and toxicity of drugs in vivo, providing powerful support for drug screening and R&D. At the same time, the platform can also conduct in-depth research on the mechanism of drug action, providing a theoretical basis for the development of new drugs.

4、Powerful interdisciplinary cooperation ability
CDX modeling platform is not only suitable for basic science research, but also can be deeply integrated with clinical research, translational medicine and other fields. InnoModels' CDX model platform provides strong support for interdisciplinary collaboration, allowing researchers to study tumors from different perspectives and at different levels. This interdisciplinary research approach helps to discover new treatments and methods and promote the in-depth development of tumor research.
5. High attention to ethics and compliance
When using patient-derived tissues for research, the issues of ethics and compliance are particularly important. In the design and operation of the CDX model platform, InnoModels strictly abides by relevant ethical and regulatory requirements to ensure that patients' privacy and rights are fully protected. At the same time, the platform also focuses on animal welfare and ethical issues to minimize pain and harm to animals.
6. Summary
With its unique features such as highly restoring the real tumor environment, personalized therapeutic strategy research, efficient drug screening and development, strong interdisciplinary cooperation capabilities, and high attention to ethics and compliance, the CDX model platform of InnoModels Biotechnology has demonstrated great potential and value in the field of oncology research. With the continuous progress and improvement of the technology, it is believed that the CDX model platform will play an even more important role in future tumor research and make greater contributions to human health.

InnoModels' In Vitro Killing Experimental Platform: An Innovative Tool to Uncover the Mechanisms of Cytotoxicity

InnoModels Biotechnology: Introduction to the main features of the in vivo tumor experimental platform

InnoModels' In Vitro Killing Experimental Platform: An Innovative Tool to Uncover the Mechanisms of Cytotoxicity

InnoModels Biotechnology: Introduction to the main features of the in vivo tumor experimental platform

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License